34 related articles for article (PubMed ID: 17148033)
21. Pharmacological insights from P-glycoprotein knockout mice.
Schinkel AH
Int J Clin Pharmacol Ther; 1998 Jan; 36(1):9-13. PubMed ID: 9476142
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy with drug resistance genes.
Zaboikin M; Srinivasakumar N; Schuening F
Cancer Gene Ther; 2006 Apr; 13(4):335-45. PubMed ID: 16211086
[TBL] [Abstract][Full Text] [Related]
23. [Gene therapy for breast cancer].
Takahashi S; Sugimoto Y
Nihon Rinsho; 2005 Mar; 63(3):476-82. PubMed ID: 15773348
[TBL] [Abstract][Full Text] [Related]
24. [Gene therapy for relapsed breast cancer].
Takahashi S; Sugimoto Y
Nihon Rinsho; 2006 Mar; 64(3):563-9. PubMed ID: 16529050
[TBL] [Abstract][Full Text] [Related]
25. Genetic manipulation of drug sensitivity in haematopoietic cells.
Southgate T; Fairbairn LJ
Expert Rev Mol Med; 2004 Aug; 6(18):1-24. PubMed ID: 15387894
[TBL] [Abstract][Full Text] [Related]
26. Restoration of transgene expression in hematopoietic cells with drug-selectable marker genes.
Licht T; Peschel C
Curr Gene Ther; 2002 May; 2(2):227-34. PubMed ID: 12109218
[TBL] [Abstract][Full Text] [Related]
27. [Study of the multidrug gene transfer to bone narrow hematopoietic cells and clinical uses].
Meng Y; Chen X; Zhang M
Zhonghua Xue Ye Xue Za Zhi; 1998 May; 19(5):277-9. PubMed ID: 11243125
[No Abstract] [Full Text] [Related]
28. Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivo.
Buss EC; Laufs S; Naundorf S; Kuehlcke K; Nagy KZ; Zeller WJ; Fruehauf S
Cytotherapy; 2006; 8(6):562-9. PubMed ID: 17148033
[TBL] [Abstract][Full Text] [Related]
29. Transfer of the MDR1 (multidrug resistance) gene: protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo.
Licht T; Gottesman MM; Pastan I
Cytokines Mol Ther; 1995 Mar; 1(1):11-20. PubMed ID: 9384659
[TBL] [Abstract][Full Text] [Related]
30. Retroviral transfer of the multidrug resistance-1 gene into lineage-committed and primitive hemopoietic cells.
Fruehauf S; Boesen JJ; Breems DA; Höft R; Hundsdörfer P; Zeller WJ; Löwenberg B; Ploemacher RE; Haas R; Valerio D
Stem Cells; 1995 Dec; 13 Suppl 3():93-9. PubMed ID: 8747995
[TBL] [Abstract][Full Text] [Related]
31. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing.
Rivella S; Sadelain M
Semin Hematol; 1998 Apr; 35(2):112-25. PubMed ID: 9565154
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy for sarcoma.
Fruehauf S; Veldwijk MR; Berlinghoff S; Basara N; Baum C; Flasshove M; Hegewisch-Becker S; Kröger N; Licht T; Moritz T; Hengge UR; Zeller WJ; Laufs S
Cells Tissues Organs; 2002; 172(2):133-44. PubMed ID: 12426490
[TBL] [Abstract][Full Text] [Related]
33. Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.
Baum C; Eckert HG; Stockschläder M; Just U; Hegewisch-Becker S; Hildinger M; Uhde A; John J; Ostertag W
J Hematother; 1996 Aug; 5(4):323-9. PubMed ID: 8877707
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
